VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
Condition:   Overactive BladderInterventions:   Drug: Succinate of Solifenacin;   Drug: Placebo of Succinate of SolifenacinSponsor:   Center Eugene MarquisNot yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2016 Category: Research Source Type: clinical trials